Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

HG-829 reverses resistance to antineoplastic agents in vitro and in vivo

Dec. 16, 2010

CCX-721 has antitumor effects in murine model of multiple myeloma

Dec. 15, 2010

Tasocitinib shows promising pharmacokinetics in ocular tissues

Dec. 15, 2010

ATL-313 and dexamethasone have synergistic antitumor effect in models of multiple myeloma

Dec. 15, 2010

EyeGene's EGT-022 shows therapeutic potential in retinopathy model

Dec. 14, 2010

Nerviano discloses promising preclinical/clinical data on new oncolytic compounds

Dec. 14, 2010

Kinase inhibitors from Bayer show oncolytic activity alone and in combination

Dec. 14, 2010

Phase I and preclinical data presented on PD-0332991 in multiple myeloma

Dec. 14, 2010

Oncolytic agent S-110 shows promising preclinical results and advances into clinic

Dec. 13, 2010

Adding ganitumab to exemestane or fulvestrant does not improve PFS in patients with breast cancer

Dec. 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...